Published in Cancer Res on July 01, 2007
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
New wirings in the survivin networks. Oncogene (2008) 1.76
Targeting survivin in cancer. Cancer Lett (2012) 1.44
Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One (2010) 1.37
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res (2010) 1.37
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33
Targeting NR4A1 (TR3) in cancer cells and tumors. Expert Opin Ther Targets (2011) 1.16
Sequence and structural analyses of nuclear export signals in the NESdb database. Mol Biol Cell (2012) 1.15
Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood (2010) 1.09
Survivin - The inconvenient IAP. Semin Cell Dev Biol (2015) 1.04
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer. Clin Cancer Res (2011) 1.03
Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis. Cell Death Dis (2010) 1.03
New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas. Front Oncol (2012) 0.95
Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncol Lett (2012) 0.94
Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci U S A (2011) 0.94
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget (2012) 0.94
Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma. Int J Clin Exp Pathol (2013) 0.94
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res (2012) 0.92
Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett (2013) 0.92
Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors. J Control Release (2014) 0.91
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther (2010) 0.91
Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol (2010) 0.90
Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr (2011) 0.89
Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array. PLoS One (2013) 0.89
Importins and exportins in cellular differentiation. J Cell Mol Med (2008) 0.88
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget (2015) 0.88
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer. Oncotarget (2015) 0.87
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma. BMC Vet Res (2012) 0.85
Survivin: a unique target for tumor therapy. Cancer Cell Int (2016) 0.84
Glycogen synthase kinase 3beta induces apoptosis in cancer cells through increase of survivin nuclear localization. Cancer Lett (2008) 0.84
Targeted inhibition of survivin with YM155 promotes apoptosis of hypoxic human pulmonary arterial smooth muscle cells via the upregulation of voltage-dependent K+ channels. Mol Med Rep (2016) 0.84
Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. PLoS One (2013) 0.82
Survivin expression is associated with lens epithelial cell proliferation and fiber cell differentiation. Mol Vis (2012) 0.81
An otoprotective role for the apoptosis inhibitor protein survivin. Cell Death Dis (2010) 0.81
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol (2015) 0.81
Survivin expression in lung cancer: Association with smoking, histological types and pathological stages. Oncol Lett (2015) 0.80
Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas. Med Mol Morphol (2013) 0.79
Analysis of the functional repertoire of a mutant form of survivin, K129E, which has been linked to lung cancer. Cancer Cell Int (2014) 0.79
Suppressed diversity of survivin splicing in active rheumatoid arthritis. Arthritis Res Ther (2015) 0.79
Overexpressed oncogenic tumor-self antigens. Hum Vaccin Immunother (2014) 0.79
Translocation Biosensors - Cellular System Integrators to Dissect CRM1-Dependent Nuclear Export by Chemicogenomics. Sensors (Basel) (2009) 0.79
Effects of full-length borealin on the composition and protein-protein interaction activity of a binary chromosomal passenger complex. Biochemistry (2009) 0.79
Taspase1: a 'misunderstood' protease with translational cancer relevance. Oncogene (2015) 0.78
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin. Mol Cancer Ther (2016) 0.78
Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression. Oncol Lett (2014) 0.78
BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients. J Cancer Res Clin Oncol (2011) 0.78
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia. Oncotarget (2017) 0.77
An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells. PLoS One (2013) 0.77
1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells. Int J Oncol (2009) 0.77
Is survivin expression prognostic or predictive in malignant pleural mesothelioma? Virchows Arch (2013) 0.77
Survivin -31 G/C polymorphism might contribute to colorectal cancer (CRC) risk: a meta-analysis. Int J Clin Exp Med (2015) 0.77
Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection. PLoS One (2013) 0.77
SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression. Beilstein J Org Chem (2013) 0.76
Assessment of mRNA splice variants by qRT-PCR. Methods Mol Biol (2013) 0.76
Targeting survivin as a potential new treatment for chondrosarcoma of bone. Oncogenesis (2016) 0.76
Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. Med Oncol (2012) 0.76
Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer. Sci Rep (2016) 0.76
Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia. Haematologica (2013) 0.76
Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer. Int J Clin Oncol (2012) 0.76
The N-terminus of survivin is a mitochondrial-targeting sequence and Src regulator. J Cell Sci (2016) 0.75
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity. Lab Invest (2016) 0.75
Survivin expression in oral lichen planus: Role in malignant transformation. J Oral Maxillofac Pathol (2016) 0.75
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. J Immunother Cancer (2015) 0.75
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene. Int J Nanomedicine (2016) 0.75
Quantification of cells expressing markers of proliferation and apoptosis in chronic tonsilitis. Acta Otorhinolaryngol Ital (2015) 0.75
Expression of chromosomal regional maintenance protein-1 may be associated with subcellular survivin expression in human gastric and colorectal carcinoma. Oncol Lett (2016) 0.75
Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget (2016) 0.75
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma. Dis Markers (2015) 0.75
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. F1000Res (2017) 0.75
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev (2006) 2.10
A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev (2009) 1.98
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J (2006) 1.25
Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir (2012) 1.15
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle (2007) 1.11
Survivin's dual role: an export's view. Cell Cycle (2007) 1.07
Reanimation of the paralyzed human larynx with an implantable electrical stimulation device. Laryngoscope (2003) 1.02
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res (2008) 1.02
Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol (2004) 1.01
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer (2009) 1.01
Cell-based analysis of structure-function activity of threonine aspartase 1. J Biol Chem (2010) 0.98
First-night-effect on polysomnographic respiratory sleep parameters in patients with sleep-disordered breathing and upper airway pathology. Eur Arch Otorhinolaryngol (2010) 0.94
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget (2012) 0.94
Spontaneous cerebrospinal fluid rhinorrhea: a clinical and anatomical study. Laryngoscope (2010) 0.94
Correlation of the Epworth Sleepiness Scale with respiratory sleep parameters in patients with sleep-related breathing disorders and upper airway pathology. Eur Arch Otorhinolaryngol (2010) 0.94
Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic (2006) 0.93
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol (2013) 0.90
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol (2007) 0.90
Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress. J Mol Cell Biol (2012) 0.90
Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol (2005) 0.90
Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer (2007) 0.88
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation. Cell Signal (2012) 0.88
Localization of congenital tegmen tympani defects. Otol Neurotol (2007) 0.87
Nuclear receptors in head and neck cancer: current knowledge and perspectives. Int J Cancer (2010) 0.87
Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Laryngoscope (2004) 0.86
Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm. PLoS One (2012) 0.86
Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene--a case report. Head Neck (2008) 0.85
Cerebrospinal fluid leaks of temporal bone origin: etiology and management. ORL J Otorhinolaryngol Relat Spec (2005) 0.84
No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine (Lond) (2015) 0.84
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. Int J Cancer (2007) 0.83
Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure. Eur Arch Otorhinolaryngol (2006) 0.83
Differential regulation of PML-RARα stability by the ubiquitin ligases SIAH1/SIAH2 and TRIAD1. Int J Biochem Cell Biol (2011) 0.83
DPOAE-grams in patients with acute tonal tinnitus. Otolaryngol Head Neck Surg (2005) 0.83
Akt and c-Jun N-terminal kinase are regulated in response to moderate noise exposure in the cochlea of guinea pigs. ORL J Otorhinolaryngol Relat Spec (2007) 0.82
Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Otol Neurotol (2011) 0.82
Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec (2010) 0.82
Endothelial nitric oxide synthase upregulation in the guinea pig organ of Corti after acute noise trauma. Brain Res (2005) 0.82
Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo. FASEB J (2012) 0.81
Association between surgical steps and intraoperative auditory brainstem response and electrocochleography waveforms during hearing preservation vestibular schwannoma surgery. Eur Arch Otorhinolaryngol (2008) 0.81
Post-operative complications after removal of sporadic vestibular schwannoma via retrosigmoid-suboccipital approach: current diagnosis and management. Eur Arch Otorhinolaryngol (2011) 0.81
An update on the pathobiological relevance of nuclear receptors for cancers of the head and neck. Histol Histopathol (2010) 0.81
The importin-alpha/nucleophosmin switch controls taspase1 protease function. Traffic (2011) 0.80
Expression analysis suggests a potential cytoprotective role of Birc5 in the inner ear. Mol Cell Neurosci (2010) 0.79
Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin. Gene (2010) 0.79
Translocation Biosensors - Cellular System Integrators to Dissect CRM1-Dependent Nuclear Export by Chemicogenomics. Sensors (Basel) (2009) 0.79
A tailor-made specific anion-binding motif in the side chain transforms a tetrapeptide into an efficient vector for gene delivery. Angew Chem Int Ed Engl (2015) 0.79
Vestibular function after acoustic neuroma removal with preservation of one branch of the vestibular nerve. Otol Neurotol (2002) 0.77
Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotransplantability and tumour progression in mice. Oncol Rep (2002) 0.77
Localization of the two constitutively expressed nitric oxide synthase isoforms (nNOS and eNOS) in the same cell types in the saccule maculae of the frog Rana pipiens by immunoelectron microscopy: evidence for a back-up system? J Electron Microsc (Tokyo) (2003) 0.77
Acute effects of 1,1,1-trichloroethane on human olfactory functioning. Am J Rhinol (2004) 0.77
Comparison of electronystagmography results with dynamic posturography findings in patients with vestibular schwannoma. Acta Otolaryngol (2007) 0.76
An Old Flame Never Dies: Survivin in Cancer and Cellular Senescence. Gerontology (2015) 0.76
Evolutionary divergence of Threonine Aspartase1 leads to species-specific substrate recognition. Biol Chem (2015) 0.76
Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells. PLoS One (2012) 0.76
MGMT activity in mucosal epithelium and squamous cell carcinoma of the head and neck. Anticancer Res (2010) 0.76
Targeting Taspase1 for cancer therapy--letter. Cancer Res (2012) 0.75
Influence of nerve of origin and tumor size of vestibular schwannoma on dynamic posturography findings. Acta Otolaryngol (2006) 0.75
Evidence for a possible NOS back-up system in the organ of Corti of the guinea pig. Eur Arch Otorhinolaryngol (2003) 0.75
Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma. Acta Otolaryngol (2007) 0.75
Steroid and vasoactive treatment for acute deafness after attempted hearing preservation acoustic neuroma surgery. ORL J Otorhinolaryngol Relat Spec (2005) 0.75
Transient evoked otoacoustic emissions in vestibular neuritis. Ann Otol Rhinol Laryngol (2006) 0.75
Treatment for adult idiopathic and Wegener-associated subglottic stenosis. Eur Arch Otorhinolaryngol (2012) 0.75
Cochlear implantation after surgery for bilateral jugular foramen paragangliomas: a case report. Eur Arch Otorhinolaryngol (2008) 0.75
Dynamic posturography findings predict balance status in vestibular schwannoma patients. Otol Neurotol (2007) 0.75
Patterns of anomalies of structures of the middle ear and the facial nerve as revealed in newborn temporal bones. Otol Neurotol (2013) 0.75
Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma. ORL J Otorhinolaryngol Relat Spec (2004) 0.75
Role of the host microenvironment on the expression of VEGF-subtypes in squamous cell carcinoma. Oncol Rep (2003) 0.75
The MED-EL SONATATI 100 cochlear implant: an evaluation of its safety in adults and children. Acta Otolaryngol (2011) 0.75